{"id":2434,"date":"2025-01-14T18:31:17","date_gmt":"2025-01-14T15:31:17","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2434"},"modified":"2025-01-14T18:31:19","modified_gmt":"2025-01-14T15:31:19","slug":"immunoforge-receives-fda-ind-approval-for-phase-2-clinical-trial-of-pemziviptadil-for-dmd-cardiomyopathy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/es\/immunoforge-receives-fda-ind-approval-for-phase-2-clinical-trial-of-pemziviptadil-for-dmd-cardiomyopathy\/","title":{"rendered":"ImmunoForge recibe la aprobaci\u00f3n FDA IND para el ensayo cl\u00ednico de fase 2 de &#039;Pemziviptadil&#039; para la miocardiopat\u00eda con DMD"},"content":{"rendered":"<p class=\"wp-block-paragraph\">El pemziviptadil, un medicamento para la miocardiopat\u00eda por DMD, se utiliza una vez a la semana y se basa en la plataforma ELP (plataforma de polip\u00e9ptidos similares a elastina) de ImmunForge, una plataforma farmacol\u00f3gica de acci\u00f3n prolongada. Para mejorar la funci\u00f3n card\u00edaca, el pemziviptadil, un p\u00e9ptido intestinal vasoactivo (VIP), act\u00faa preferentemente sobre el receptor 2 del p\u00e9ptido intestinal vasoactivo (VPAC2) para promover la contracci\u00f3n y la relajaci\u00f3n card\u00edacas.<\/p>","protected":false},"excerpt":{"rendered":"<p>El pemziviptadil, un medicamento para la miocardiopat\u00eda por DMD, se utiliza una vez a la semana y se basa en la plataforma ELP (plataforma de polip\u00e9ptidos similares a elastina) de ImmunForge, una plataforma farmacol\u00f3gica de acci\u00f3n prolongada. Para mejorar la funci\u00f3n card\u00edaca, el pemziviptadil, un p\u00e9ptido intestinal vasoactivo (VIP), act\u00faa preferentemente sobre el receptor 2 del p\u00e9ptido intestinal vasoactivo (VPAC2) para promover la contracci\u00f3n y la relajaci\u00f3n card\u00edacas.<\/p>","protected":false},"author":1,"featured_media":2436,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[66,156,157,159,158],"class_list":["post-2434","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-duchenne-muscular-dystrophy","tag-immunoforge","tag-pemziviptadil","tag-pf1804","tag-south-korea"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/2434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/comments?post=2434"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/2434\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media\/2436"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media?parent=2434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/categories?post=2434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/tags?post=2434"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}